Search

Your search keyword '"Eklund, Martin"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Eklund, Martin" Remove constraint Author: "Eklund, Martin" Region sweden Remove constraint Region: sweden
28 results on '"Eklund, Martin"'

Search Results

1. Operative versus Nonoperative Treatment of Proximal Hamstring Avulsions.

2. Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists.

3. Real world treatment utilization patterns in patients with castration-resistant prostate cancer.

4. The economic burden of prostate cancer - a Swedish prevalence-based register study.

5. Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy.

6. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.

7. Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.

8. Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists.

9. Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study.

10. Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening: The STHLM3-MRI Randomized Clinical Trial.

11. Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study.

12. External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort.

13. Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality.

14. Range of Radiologist Performance in a Population-based Screening Cohort of 1 Million Digital Mammography Examinations.

15. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.

16. Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml.

17. Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.

18. The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort.

19. A natural history model for planning prostate cancer testing: Calibration and validation using Swedish registry data.

20. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging.

21. Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study.

22. The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing.

23. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential.

24. Balancing Overdiagnosis and Early Detection of Prostate Cancer using the Stockholm-3 Model.

25. Effects of pre-notification, invitation length, questionnaire length and reminder on participation rate: a quasi-randomised controlled trial.

26. Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis.

27. Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study.

28. The effects of selection, drift and genetic variation on life-history trait divergence among insular populations of natterjack toad, Bufo calamita.

Catalog

Books, media, physical & digital resources